HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

LAEKNA-B

18.010

-0.300-1.64%

Volume:2.91M

Turnover:53.25M

Market Cap:7.38B

PE:-23.16

High:19.000

Open:18.290

Low:17.720

Close:18.310

52wk High:23.500

52wk Low:4.200

Shares:410.00M

HK Float Shares:410.00M

Volume Ratio:0.91

T/O Rate:0.71%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.777

ROE:-34.59%

ROA:-19.92%

PB:9.47

PE(LYR):-23.16

PS:1459.56

Loading ...

Overview Company News Filings

LAEKNA-B (02105) Plans to Place 36 Million Shares at Approximately 9.5% Discount, Raising Net Proceeds of About HK$577.5 Million

Laekna Inc. Announces Private Placement of New Shares to Strengthen Financial Position

Laekna - Conditionally Agreed to Place Aggregate 36 Mln Placing Shares at HK$16.30 per Placing Share

THOMSON REUTERS

LAEKNA-B (02105) Issues 2.73 Million Ordinary Shares Under 2024 Share Incentive Plan

HK Movers｜Pharma Stocks Jumped. 3S Bio up 15%; Laekna up 8%; Junshi up 7%; HBM, SKB Bio and TigerMed up 6%.

Tiger Newspress

Stock Track | LAEKNA-B Soars 7.43% Amid Biotech Stock Rally in Hong Kong

HK Movers | Biotech Stocks Jump With Transcenta up 9%

Tiger Newspress

Laekna Trims Loss in H1 as Revenue Jumps 41%

MT Newswires Live

Laekna Inc - Hy Loss RMB129.6 Mln

THOMSON REUTERS

BRIEF-Laekna Obtains FDA Approval Of Investigational New Drug For LAE103

Laekna Inc. Secures FDA Approval for Investigational New Drug LAE103 Targeting Sarcopenic Obesity

Laekna Inc - Obtains FDA Approval of Investigational New Drug for Lae103

THOMSON REUTERS

Laekna Inc. Board to Convene for Interim Results Approval and Publication

Laekna Inc. Submits Investigational New Drug Application for LAE103 to the U.S. FDA for Treatment of Sarcopenic Obesity and Muscle-Related Disease

HK Movers | Biotech Stocks Surge With JW Therap up 20%, RemeGen up 13%

Tiger Newspress

Laekna Inc. Announces Presentation of Clinical and Preclinical Study Results for LAE02, LAE03, and LAE123 at 2025 ADA

Laekna Inc. Conducted Annual General Meeting

HK Movers | HK's Pharma Shares Soar. Hengrui Pharma Surges 29%; Asymchem up 7%; CSPC Pharma up 4%

Tiger Newspress

HK Movers | HK's Biotech Shares Soar. Asymchem up 15%; Laekna up 13%; Ascletis, CanSinoBIO up 9%

Tiger Newspress

Laekna Inc. Announces Grant of 11.46 Million Restricted Share Units Under 2024 Share Award Scheme

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02105/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"LAEKNA-B","latestPrice":18.01,"timestamp":1757405293001,"preClose":18.31,"halted":0,"volume":2913000,"delay":0,"floatShares":409999999,"shares":409999999,"eps":-0.7774740284592737,"marketStatus":"Not Yet Opened","change":-0.3,"latestTime":"09-09 16:08:13","open":18.29,"high":19,"low":17.72,"amount":53253120,"amplitude":0.069907,"askPrice":18.01,"askSize":15500,"bidPrice":18,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.7150599206738633,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1757467800000},"marketStatusCode":0,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":18.31,"openAndCloseTimeList":[[1757381400000,1757390400000],[1757394000000,1757404800000]],"volumeRatio":0.9062222657751046,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":409999999,"roa":"-19.92%","roe":"-34.59%","lyrEps":-0.777474,"volumeRatio":0.9062222657751046,"shares":409999999,"dividePrice":0,"high":19,"amplitude":0.069907,"preClose":18.31,"low":17.72,"week52Low":4.2,"pbRate":"9.47","psRate":"1459.56","week52High":23.5,"institutionHeld":0,"latestPrice":18.01,"committee":-0.878788,"eps":-0.7774740284592737,"divideRate":0,"volume":2913000,"delay":0,"ttmEps":-0.7150599206738633,"open":18.29,"prevYearClose":9.37,"prevWeekClose":17.05,"prevMonthClose":16.35,"prevQuarterClose":17.46,"fiveDayClose":15.61,"twentyDayClose":18.62,"sixtyDayClose":22.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2025-08-13","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755048600000,"name":null,"time":"","dateTimestamp":1755014400000,"actualEps":null},{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"Post Market","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-24","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692840600000,"name":null,"time":"","dateTimestamp":1692806400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1754323200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2025-09-08","current":-26.65488,"percent":0.027624,"low":-30.832985,"twenty":-17.476745,"median":-8.540978,"eighty":-4.882036,"high":-1.640852,"avg":-11.026477,"sd":7.327788,"marketCap":6998878851},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466},{"date":"2025-04-25","current":-18.85387,"twenty":-11.890039,"median":-7.064143,"eighty":-4.482534,"marketCap":5103616142},{"date":"2025-05-02","current":-20.273816,"twenty":-12.024603,"median":-7.138152,"eighty":-4.483904,"marketCap":5499650777},{"date":"2025-05-09","current":-20.37867,"twenty":-12.272607,"median":-7.171338,"eighty":-4.537135,"marketCap":5566901942},{"date":"2025-05-16","current":-19.209634,"twenty":-12.535336,"median":-7.205238,"eighty":-4.575802,"marketCap":5290424932},{"date":"2025-05-23","current":-24.021586,"twenty":-12.71305,"median":-7.273665,"eighty":-4.590948,"marketCap":6635448220},{"date":"2025-05-30","current":-24.266566,"twenty":-12.811921,"median":-7.298393,"eighty":-4.611692,"marketCap":6732588791},{"date":"2025-06-06","current":-26.139049,"twenty":-13.04892,"median":-7.396066,"eighty":-4.640938,"marketCap":7270598106},{"date":"2025-06-13","current":-29.74055,"twenty":-13.19671,"median":-7.470293,"eighty":-4.681154,"marketCap":8275629397},{"date":"2025-06-20","current":-28.050034,"twenty":-13.86335,"median":-7.533906,"eighty":-4.700982,"marketCap":7789926543},{"date":"2025-06-27","current":-24.148232,"twenty":-14.651862,"median":-7.597268,"eighty":-4.71884,"marketCap":6725116440},{"date":"2025-07-04","current":-23.234874,"twenty":-14.895898,"median":-7.634748,"eighty":-4.738772,"marketCap":6471056485},{"date":"2025-07-11","current":-22.291445,"twenty":-15.089879,"median":-7.696392,"eighty":-4.760215,"marketCap":6202051828},{"date":"2025-07-18","current":-26.31753,"twenty":-15.471722,"median":-7.782262,"eighty":-4.775945,"marketCap":7316474020},{"date":"2025-07-25","current":-25.476909,"twenty":-15.613487,"median":-7.864399,"eighty":-4.786942,"marketCap":7108532126},{"date":"2025-08-01","current":-24.329935,"twenty":-15.664049,"median":-8.108989,"eighty":-4.797184,"marketCap":6746559201},{"date":"2025-08-08","current":-25.903798,"twenty":-15.966112,"median":-8.199572,"eighty":-4.803824,"marketCap":7200950746},{"date":"2025-08-15","current":-26.404653,"twenty":-16.351868,"median":-8.297938,"eighty":-4.809409,"marketCap":6923694888},{"date":"2025-08-22","current":-24.957996,"twenty":-16.76437,"median":-8.37361,"eighty":-4.821672,"marketCap":6523837408},{"date":"2025-08-29","current":-23.625619,"twenty":-17.081215,"median":-8.510167,"eighty":-4.847599,"marketCap":6205046052},{"date":"2025-09-05","current":-24.661552,"twenty":-17.4013,"median":-8.538507,"eighty":-4.876556,"marketCap":6470705516},{"date":"2025-09-08","current":-26.65488,"twenty":-17.476745,"median":-8.540978,"eighty":-4.882036,"marketCap":6998878851}],"updateTime":1757435449224},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1173885516","title":"LAEKNA-B (02105) Plans to Place 36 Million Shares at Approximately 9.5% Discount, Raising Net Proceeds of About HK$577.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1173885516","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173885516?lang=en_us&edition=fundamental","pubTime":"2025-09-10 06:28","pubTimestamp":1757456895,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) announced that on September 10, 2025, the company intends to place a total of 36 million placement shares, representing approximately 8.1% of the company's enlarged issued share...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2566649814","title":"Laekna Inc. Announces Private Placement of New Shares to Strengthen Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2566649814","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566649814?lang=en_us&edition=fundamental","pubTime":"2025-09-10 06:12","pubTimestamp":1757455977,"startTime":"0","endTime":"0","summary":"Laekna Inc., a biopharmaceutical company incorporated in the Cayman Islands, has announced a private placement of new shares under a general mandate. The placement aims to expand the shareholder and capital base of the company. Merrill Lynch  Limited is acting as the sole placing agent and overall coordinator for the offering. The proceeds from the placement are intended to strengthen Laekna's financial position and support future development initiatives. The Board believes this strategic move is in the best interests of both the company and its shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laekna Inc. published the original content used to generate this news brief on September 10, 2025, and is solely responsible for the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDL11sr1P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861165.SGD","BAC","LU0640476718.USD","IE00B7SZLL34.SGD","LU1069347547.HKD","LU0130102774.USD","LU1883839398.USD","LU1880398471.USD","BK1161","LU0256863811.USD","LU0306806265.USD","LU0477156797.USD","LU0234572021.USD","LU1280957306.USD","LU1894683264.USD","LU0314106906.USD","LU0130517989.USD","LU0130518102.USD","LU1880398554.USD","LU0070302665.USD","LU0203347892.USD","LU1267930227.SGD","IE00B1BXHZ80.USD","LU0683600562.USD","LU0149725797.USD","LU1074936037.SGD","02105","LU1496350502.SGD","LU0417517546.SGD","BK4534","LU0321505868.SGD","IE00BFXG1179.USD","BK4559","LU0052756011.USD","IE00B19Z3581.USD","LU0787776722.HKD","LU1366192091.USD","LU0868494617.USD","LU1496350171.SGD","IE00BKVL7J92.USD","LU0648001328.SGD","LU1894683348.USD","LU0203345920.USD","BK4553","LU1035773651.USD","LU0256863902.USD","IE0002270589.USD","LU1201861249.SGD","LU0971096721.USD","BK4504"],"gpt_icon":0},{"id":"2566649816","title":"Laekna - Conditionally Agreed to Place Aggregate 36 Mln Placing Shares at HK$16.30 per Placing Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2566649816","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566649816?lang=en_us&edition=fundamental","pubTime":"2025-09-10 06:12","pubTimestamp":1757455941,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UW0WA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1132124944","title":"LAEKNA-B (02105) Issues 2.73 Million Ordinary Shares Under 2024 Share Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1132124944","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132124944?lang=en_us&edition=fundamental","pubTime":"2025-09-07 19:56","pubTimestamp":1757246204,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) announced that the company issued a total of 2.73 million ordinary shares on September 5, 2025, to satisfy the vesting of restricted stock units (RSUs) granted under the 2024 share incentive plan.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"gpt_icon":0},{"id":"1124534856","title":"HK Movers｜Pharma Stocks Jumped. 3S Bio up 15%; Laekna up 8%; Junshi up 7%; HBM, SKB Bio and TigerMed up 6%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1124534856","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124534856?lang=en_us&edition=fundamental","pubTime":"2025-09-05 14:16","pubTimestamp":1757052966,"startTime":"0","endTime":"0","summary":"HK Pharma Stocks Jumped. 3S Bio up 15%; Laekna up 8%; Junshi up 7%; HBM, SKB Bio and TigerMed up 6%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"94a36d9e9ad684c6a1c23071984751f8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","01530","01877"],"gpt_icon":0},{"id":"1163077419","title":"Stock Track | LAEKNA-B Soars 7.43% Amid Biotech Stock Rally in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=1163077419","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163077419?lang=en_us&edition=fundamental","pubTime":"2025-08-19 10:02","pubTimestamp":1755568962,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105), also known as LaiKang Medicine, saw its stock price soar by 7.43% during early trading on Tuesday, outperforming the broader biotech sector in Hong Kong. The significant uptick...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3c69330474cfca501aba698b1d21b7cf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02105"],"gpt_icon":0},{"id":"1105286865","title":"HK Movers | Biotech Stocks Jump With Transcenta up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1105286865","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105286865?lang=en_us&edition=fundamental","pubTime":"2025-08-19 10:01","pubTimestamp":1755568884,"startTime":"0","endTime":"0","summary":"On August 19 (Tuesday), Hong Kong biotech stocks were active in early trading. Transcenta rose 9%, LaiKang Medicine rose 6%, Venus Medtech rose 4%, Kelun-Biotech Biopharmaceutical rose 3%, Luzhu Biotechnology rose 2%, ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3c69330474cfca501aba698b1d21b7cf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500","02480","06628","06990","02105"],"gpt_icon":0},{"id":"2559874189","title":"Laekna Trims Loss in H1 as Revenue Jumps 41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559874189","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559874189?lang=en_us&edition=fundamental","pubTime":"2025-08-14 07:56","pubTimestamp":1755129419,"startTime":"0","endTime":"0","summary":"Laekna  narrowed its loss to 129.6 million yuan in the first half of 2025 from 143.7 million yuan a year prior, a Wednesday Hong Kong bourse filing said.The pharmaceutical firm's loss per share shrank to 0.35 yuan from 0.40 yuan in the year-ago period.Other income for the interim period rose 41% to 19.9 million yuan from 14.1 million yuan a year prior, mainly due to higher government grants.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02105"],"gpt_icon":0},{"id":"2559608468","title":"Laekna Inc -  Hy Loss RMB129.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2559608468","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559608468?lang=en_us&edition=fundamental","pubTime":"2025-08-13 17:03","pubTimestamp":1755075821,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nFWN3U50CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2555769009","title":"BRIEF-Laekna Obtains FDA Approval Of Investigational New Drug For LAE103","url":"https://stock-news.laohu8.com/highlight/detail?id=2555769009","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555769009?lang=en_us&edition=fundamental","pubTime":"2025-07-31 15:00","pubTimestamp":1753945232,"startTime":"0","endTime":"0","summary":"BRIEF-Laekna Obtains FDA Approval Of Investigational New Drug For LAE103July 31 (Reuters) - Laekna Inc 2105.HK:OBTAINS FDA APPROVAL OF INVESTIGATIONAL NEW DRUG FOR LAE103Further company coverage: 2105.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nFWN3TR29Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2555077162","title":"Laekna Inc. Secures FDA Approval for Investigational New Drug LAE103 Targeting Sarcopenic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2555077162","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555077162?lang=en_us&edition=fundamental","pubTime":"2025-07-31 12:06","pubTimestamp":1753934803,"startTime":"0","endTime":"0","summary":"Laekna Inc., a company incorporated in the Cayman Islands, has announced that it has obtained Investigational New Drug  approval from the U.S. Food and Drug Administration  for its internally discovered monoclonal antibody, LAE103. This approval marks a significant step in advancing LAE103, an ActRIIB selective antibody, to clinical studies aimed at treating sarcopenic obesity and other muscle-related diseases. The company emphasizes that while this approval is a crucial milestone, there remains the risk that LAE103 may not ultimately be successfully developed and commercialized. The announcement serves to inform shareholders and potential investors of this important business update.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laekn","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nNDL3m80lh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2555077648","title":"Laekna Inc - Obtains FDA Approval of Investigational New Drug for Lae103","url":"https://stock-news.laohu8.com/highlight/detail?id=2555077648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555077648?lang=en_us&edition=fundamental","pubTime":"2025-07-31 12:01","pubTimestamp":1753934517,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nFWN3TR29Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2555035245","title":"Laekna Inc. Board to Convene for Interim Results Approval and Publication","url":"https://stock-news.laohu8.com/highlight/detail?id=2555035245","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555035245?lang=en_us&edition=fundamental","pubTime":"2025-07-29 16:35","pubTimestamp":1753778129,"startTime":"0","endTime":"0","summary":"Laekna Inc. has announced that its Board of Directors will meet on Wednesday, 13 August 2025. During this meeting, the Board will consider and approve the interim results of the company and its subsidiaries for the six months ended on 30 June 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laekna Inc. published the original content used to generate this news brief on July 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250729:nNDLbdtCNV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2547035421","title":"Laekna Inc. Submits Investigational New Drug Application for LAE103 to the U.S. FDA for Treatment of Sarcopenic Obesity and Muscle-Related Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2547035421","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547035421?lang=en_us&edition=fundamental","pubTime":"2025-06-30 08:14","pubTimestamp":1751242495,"startTime":"0","endTime":"0","summary":"Laekna Inc. Submits Investigational New Drug Application for LAE103 to the U.S. FDA for Treatment of Sarcopenic Obesity and Muscle-Related Disease. Laekna Inc. has voluntarily announced the submission of an Investigational New Drug  application to the U.S. Food and Drug Administration  for their internally discovered monoclonal antibody, LAE103. This precision therapy is being developed to treat sarcopenic obesity and muscle-related diseases. As part of their ongoing regulatory review, Laekna plans to evaluate the efficacy and safety of monoclonal antibodies targeting ActRIIA and ActRIIB in humans. It is important to note that LAE103 is still in development, and its successful commercialization is not guaranteed. The company's shareholders and potential investors are advised to exercise caution.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDLv9DMj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"gpt_icon":0},{"id":"1153382861","title":"HK Movers | Biotech Stocks Surge With JW Therap up 20%, RemeGen up 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153382861","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153382861?lang=en_us&edition=fundamental","pubTime":"2025-06-24 15:37","pubTimestamp":1750750670,"startTime":"0","endTime":"0","summary":"Biotech stocks surged in Hong Kong. JW Therap rose 20%; RemeGen rose 13%; Biocytogen rose 9%; Laekna rose 6%; WuXi AppTec and WuXi Biologics rose 4%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"6ad0cd2bbc029d6042829c5820aaa306","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","02105","02126","02359","02269","02315"],"gpt_icon":0},{"id":"2545451309","title":"Laekna Inc. Announces Presentation of Clinical and Preclinical Study Results for LAE02, LAE03, and LAE123 at 2025 ADA","url":"https://stock-news.laohu8.com/highlight/detail?id=2545451309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545451309?lang=en_us&edition=fundamental","pubTime":"2025-06-23 08:03","pubTimestamp":1750637003,"startTime":"0","endTime":"0","summary":"Laekna, Inc., a company incorporated in the Cayman Islands, has announced the presentation of clinical and preclinical study results for its drug candidates, LAE02, LAE03, and LAE123, at the 85th scientific sessions of the American Diabetes Association  held in 2025. The studies focused on the potential use of these drugs for muscle growth and fat reduction. The results included data from the phase I SAD study of LAE102, an ActRIIA-selective antibody, for treating obesity. This study involved both intravenous and subcutaneous cohorts and concluded that LAE102 was well tolerated, with no serious adverse events reported. The presentations took place on June 22, 2025, at the McCormick Place Convention Center in Chicago, Illinois, USA. Shareholders and potential investors are advised to exercise caution, as these drug candidates may not ultimately be successfully developed and commercialized.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDL4yBd2n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2540770447","title":"Laekna Inc. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2540770447","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540770447?lang=en_us&edition=fundamental","pubTime":"2025-06-03 22:36","pubTimestamp":1748961369,"startTime":"0","endTime":"0","summary":"Laekna Inc. held its Annual General Meeting on June 3, 2025. During the meeting, several proposals were presented and approved. These included the re-election of Dr. Lu Chris Xiangyang as a director, the re-election of Ms. Xie Ling as a director, and the re-election of Dr. Gu Xiang-Ju Justin as a director. The appointment of the Company's auditor was also approved. Additionally, a general mandate to issue shares and a general mandate to repurchase shares were granted. All resolutions proposed at the meeting were successfully passed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laekna Inc. published the original content used to generate this news brief on June 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL5z51lp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1133424631","title":"HK Movers | HK's Pharma Shares Soar. Hengrui Pharma Surges 29%; Asymchem up 7%; CSPC Pharma up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133424631","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133424631?lang=en_us&edition=fundamental","pubTime":"2025-05-23 10:09","pubTimestamp":1747966164,"startTime":"0","endTime":"0","summary":"Hong Kong’s pharma stocks rose on Friday.Hengrui Pharma surged 29%; Asymchem rose 7%; CSPC Pharma rose 4%; Hutchmed, Innovent Bio, Laekna rose 3%; CanSinoBIO rose 2%.Hengrui, which is based in eastern China’s Jiangsu province, began operations in 1970 as state-owned Lianyungang Pharmaceutical Factory. It listed in Shanghai in 2000.Over the years, it has shifted focus to developing novel drugs from making generic medicines. It has spent 44 billion yuan  on R&D since 2000, according to its website","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"97c4ce10e0d7371cbbe9d36dff321fe2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","01276","00013","06185","06821","01093","01801"],"gpt_icon":1},{"id":"1199180560","title":"HK Movers | HK's Biotech Shares Soar. Asymchem up 15%; Laekna up 13%; Ascletis, CanSinoBIO up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199180560","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199180560?lang=en_us&edition=fundamental","pubTime":"2025-05-21 11:19","pubTimestamp":1747797557,"startTime":"0","endTime":"0","summary":"Hong Kong’s biotech stocks rose on Tuesday.Asymchem rose 15%; Laekna rose 13%; Ascletis, CanSinoBIO rose 9%; Junshi Bio, Cstone Pharma rose 8%; 3SBio soared 7%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"305e35af160080a1ff409fd71b17ab9e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","02137","03347","02359","06185","02268","01672","01530","02269","06978","09966","02105","01877","09995","06821","06606","09688","03759"],"gpt_icon":1},{"id":"2533134128","title":"Laekna Inc. Announces Grant of 11.46 Million Restricted Share Units Under 2024 Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2533134128","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533134128?lang=en_us&edition=fundamental","pubTime":"2025-05-08 22:29","pubTimestamp":1746714557,"startTime":"0","endTime":"0","summary":"Laekna Inc., a company incorporated in the Cayman Islands, has announced the grant of 11,460,000 Restricted Share Units  to various grantees, including three executive directors, as part of its 2024 Share Award Scheme. The announcement, made on May 8, 2025, outlines that the RSUs represent an aggregate of 11,460,000 shares. The grant includes allocations to Dr. Lu Chris Xiangyang, Ms. Xie Ling, and Dr. Gu Xiang-Ju Justin, who are executive directors of the company. The scheme is governed by Rules 17.06A, 17.06B, and 17.06C of the Listing Rules, and there are no arrangements for financial assistance from the company to facilitate the purchase of RSUs. The total number of shares that may be issued under the scheme is capped at 39,010,035 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nNDLzyF3x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}